Form 4: Outset Medical Executive Sells Shares to Cover Tax Obligations

An Outset Medical executive, Marc Nash, sold 720 shares of common stock to cover tax obligations related to previously vested performance stock units.

Summary

• Marc Nash, SVP of Operations and R&D at Outset Medical, sold 720 shares of common stock on January 7, 2025.
• The sale was executed at a price of $1.29 per share.
• This transaction was to cover tax withholding obligations related to 1,581 shares of common stock underlying performance stock units (PSUs).
• The PSUs were originally earned on January 12, 2024, and vested on January 6, 2025.
• The sale was not a discretionary trade but a 'sell to cover' transaction to meet tax obligations.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly listed companies.
• The 'sell to cover' method is a common way for executives to manage tax liabilities associated with stock-based compensation.
• Similar transactions are regularly reported by executives at companies like Medtronic, Boston Scientific, and Stryker.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Outset Medical, insider trading, stock sale, tax obligations, performance stock units, executive compensation, Form 4